<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The incidence of <z:mp ids='MP_0002038'>carcinoma</z:mp> of the gastroesophageal junction (GEJ) is rapidly increasing, and the prognosis remains poor </plain></SENT>
<SENT sid="1" pm="."><plain>We examined outcomes in patients who received neoadjuvant <z:e sem="disease" ids="C1559154" disease_type="Disease or Syndrome" abbrv="">chemoradiation</z:e> for GEJ <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> to identify factors that predict disease-free (DFS) and overall (OS) survival </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A retrospective analysis was performed of 101 consecutive patients who received <z:e sem="disease" ids="C1559154" disease_type="Disease or Syndrome" abbrv="">chemoradiation</z:e> and surgery for GEJ <z:mp ids='MP_0002038'>carcinoma</z:mp> between 1992 and 2001 </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The median DFS and OS of <z:hpo ids='HP_0000001'>all</z:hpo> patients were 16 and 25 months, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>Twenty-eight patients with a complete histological response (T0N0) experienced greater DFS compared with <z:hpo ids='HP_0000001'>all</z:hpo> others (P = .02) </plain></SENT>
<SENT sid="5" pm="."><plain>Node-negative patients, regardless of T stage, experienced improved median DFS (24 months) compared with N1 patients (9 months; P = .01) </plain></SENT>
<SENT sid="6" pm="."><plain>Preoperative stage, age, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> location, or <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> did not independently predict OS by univariate analysis </plain></SENT>
<SENT sid="7" pm="."><plain>Multivariate analysis demonstrated that only posttreatment nodal status (P = .03)-not the degree of <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> response-predicted DFS </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The nodal status of patients with GEJ <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> after neoadjuvant therapy is predictive of DFS after resection </plain></SENT>
<SENT sid="9" pm="."><plain>The poor outcome in node-positive patients supports postneoadjuvant therapy nodal staging, because surgical <z:hpo ids='HP_0000718'>aggressiveness</z:hpo> should be tempered by the realization that cure is unlikely and median survival is short </plain></SENT>
</text></document>